Back
Top 3%
18.7%
Top 59%
9.5%
#1
8.3%
Top 0.6%
8.3%
Top 0.3%
5.9%
Top 3%
4.4%
#1
4.4%
Top 4%
3.3%
Top 15%
2.9%
Top 8%
2.1%
Top 2%
2.1%
Top 41%
1.6%
Top 1%
1.6%
Top 3%
1.4%
Top 4%
1.4%
Top 4%
1.4%
Top 0.5%
1.4%
Top 7%
1.4%
Top 26%
1.0%
Top 8%
1.0%
Top 8%
0.8%
Top 21%
0.8%
Top 8%
0.8%
Targeting MAdCAM-1 can prevent colitic cancer progression by suppressing immune cell infiltration and inflammatory signals
2022-12-20
gastroenterology
Title + abstract only
View on medRxiv
Show abstract
Chronic inflammation by infiltrating immune cells promotes colitis-associated dysplasia/colitic cancer in ulcerative colitis (UC) via activating inflammatory cytokine signalling (IL-6/p-STAT3 and TNF/NF-{kappa}B). Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is a cell adhesion molecule expressed on high endothelial venules that promote immune cell migration from the bloodstream to the gut. MAdCAM-1 targeting strategy is attracting attention as a novel therapeutic option for UC. However,...
Predicted journal destinations
1
Scientific Reports
701 training papers
2
PLOS ONE
1737 training papers
3
Gut
17 training papers
4
American Journal of Gastroenterology
15 training papers
5
Gut Microbes
15 training papers
6
Frontiers in Immunology
140 training papers
7
Biomedicines
21 training papers
8
Frontiers in Medicine
99 training papers
9
eLife
262 training papers
10
Journal of Clinical Medicine
77 training papers
11
iScience
74 training papers
12
Nature Communications
483 training papers
13
Frontiers in Pharmacology
27 training papers
14
Cell Reports Medicine
49 training papers
15
British Journal of Cancer
22 training papers
16
BMC Cancer
21 training papers
17
mSystems
16 training papers
18
Vaccines
131 training papers
19
BMC Medicine
155 training papers
20
Heliyon
57 training papers
21
Cancers
57 training papers
22
Cureus
64 training papers
23
JCI Insight
63 training papers